No Detail Found!

Bruceine a Attenuates Induced Fatty Liver Disease by Inhibiting CCR1 and Activating Autophagy in C57BL/6J Mice

Author(s)
Huixin Hu Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China;
Shiwen Liang Brain Disease Ward Three, Shenyang No. 2 hospital of traditional Chinese Medicine, Shenyang, Liaoning 110100, China;
Yang Li Department of General Surgery, Shengjing Hospital of China Medical University,Shenyang, Liaoning 110004,China
Jinpeng Liu College of Animal Science and Veterinary Medicine, Shenyang Agricultural University,Shenyang 110866,China
Tengfei Wu Department of Laboratory Animal Science, China Medical University,Shenyang, 110122,China
Yu Tian Department of General Surgery, Shengjing Hospital of China Medical University,Shenyang, Liaoning 110004,China
Abstract
Fatty liver disease (FLD) may eventually progress to a wide-ranging spectrum, involving steatosis, liver cirrhosis and even hepatocellular carcinoma. The study aimed to explore the activity and underlying mechanism of quassinoid compound Bruceine A (BA), which was extracted from traditional Chinese medicine Brucea javanica (L.) Merr., against FLD in mice. C57BL/6 mice (n=60) were divided equally into: Control (Con), FLD, BA low-, medium-, and high-dose treatment groups. FLD was induced by receiving a high-fat diet (HFD) over a 16-week period and 1, 2 and 4 mg/kg BA was administered by intraperitoneal injection every 4 days. Our study demonstrated that BA treatment significantly ameliorated FLD symptom (P<0.05 vs. FLD model group), evidenced by reduced body weight, decreased serum lipid profile, elevated hepatic function and attenuated hepatic steatosis. Moreover, reduced reactive oxygen species (ROS) and malondialdehyde (MDA) overproduction were found in FLD mice with BA treatment (P<0.05 vs. FLD model group). More significantly, network pharmacology analysis identified that BA was likely to exert therapeutic effects on FLD by down-regulating chemokine-receptor 1 (CCR1) expression, and this finding was further validated through the following in vivo experiments. Mechanistically, we revealed that BA supplementation promoted autophagosome formation and regulated the expression of autophagy-related markers, including L3II/I, P62 and Beclin1 (P<0.05 vs. FLD model group). These findings suggested that BA-induced autophagy played a crucial role in alleviating the fatty liver condition. In conclusion, this study demonstrated that BA protected against induced FLD in mice through suppression of CCR1-dependent oxidative stress and activation of autophagic pathways, thereby providing novel therapeutic insights for the management of FLD.
Publication Details
Page(s) 1403-1410
Published Journal: Pakistan Veterinary Journal, Volume: 45, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
CCR1, oxidative stress, Autophagy, BA, Fatty liver disease
References
Angeli E,Rodríguez FM,Rey F .2019 .Liver fatty acid metabolism associations with reproductive performance of dairy cattle. Anim Reprod Sci, 208 : 106104.
Barnes PJ .2022 .Chemokine receptor CCR1: new target for asthma therapy. Trends Pharmacol Sci, 43 : 539-41.
Byun S,Seok S,Kim YC .2020 .Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun, 11 : 807.
Chen CL,Lin YC .2022 .Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease:A New Therapeutic Target. Int J Mol Sci, 23 : 10055.
Cheng X,Ma X,Zhu Q .2019 .Pacer Is a Mediator of mTORC1 and GSK3-TIP60 Signaling in Regulation of Autophagosome Maturation and Lipid Metabolism. Mol Cell, 73 : 788-802.
Du C,Ma C,Geng R .2025 .Bruceine A inhibits TGF-β1/Smad pathway in pulmonary fibrosis by blocking gal3/TGF-β1 interaction. Phytomedicine, 136 : 156267.
Du X,Chen M,Fang Z .2024 .Evaluation of hepatic AMPK, mTORC1, and autophagy-lysosomal pathway in cows with mild or moderate fatty liver. J Dairy Sci, 107 : 3269-79.
Du X,Liu G,Loor JJ .2018 .Impaired hepatic autophagic activity in dairy cows with severe fatty liver is associated with inflammation and reduced liver function. J Dairy Sci, 101 : 11175-185.
Eng JM,Estall JL .1805 .Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol. Cells, 10 : .
Estes C,Razavi H,Loomba R .2018 .Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology, 67 : 123-33.
Filali-Mouncef Y,Hunter C,Roccio F .2022 .The ménage à trois of autophagy, lipid droplets and liver disease. Autophagy, 18 : 50-72.
Fujinaga H,Tsutsumi T,Yotsuyanagi H .2011 .HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology, 81 : 11-17.
Gao Y,Zhang W,Zeng LQ .2020 .Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol, 36 : 101635.
Gerloff BJ .2000 .Dry cow management for the prevention of ketosis and fatty liver in dairy cows. Vet Clin North Am Food Anim Pract, 16 : 283-92.
González-Gallego J,García-Mediavilla MV,Sánchez-Campos S .2011 .Hepatitis C virus, oxidative stress and steatosis: current status and perspectives. Curr Mol Med, 11 : 373-90.
Gross JJ .2023 .. Vet Clin North Am Food Anim Pract, 39 : 371-83.
Grummer RR .2008 .Nutritional and management strategies for the prevention of fatty liver in dairy cattle. Vet J, 176 : 10-20.
Hasan A,Repici A,Capra AP .2025 .CCR1 antagonist as a potential modulator of inflammatory, autophagic, and apoptotic markers in spinal cord injury. Neuropharmacology, 264 : 110239.
Huang Y,Zhang C,Sun X .2021 .Identification of differentially expressed miRNAs on normal cell, fatty liver cell and processed cell by monoammonium glycyrrhizinate from cattle (Bos indicus) by deep sequencing approach. Anim Biotechnol, 32 : 688-98.
Jakimowicz M,Szyda J,Jagusiak W .2025 .Genome-wide association study and enrichment analysis for clinical health traits in HolsteinFriesian cattle. Animal, 19 : 101545.
Jia Q,Cao H,Shen D .2019 .Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARγ, LXRα and ABCA1. Int J Mol Med, 44 : 893-902.
Jiang Y,Chen D,Gong Q .2021 .- associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease. Lipids Health Dis, 20 : 40.
Le-Tian Z,Cheng-Zhang H,Xuan Z .2020 .Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease. BMC Genomics, 21 : 435.
Li H,Zhao X,Zheng L .2022 .Bruceine A protects against diabetic kidney disease via inhibiting galectin-1. Kidney Int, 102 : 521-35.
Lian CY,Zhai ZZ,Li Z,F Z .2020 .High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms. Chem Biol Interact, 330 : 109199.
Lu W,Yang J,Hu M .2023 .Effects of choline deficiency and supplementation on lipid droplet accumulation in bovine primary liver cells in vitro. J Dairy Sci, 106 : 9868-78.
Nakao R,Mizukami C,Kawamura Y .2009 .Evaluation of efficacy of bruceine A, a natural quassinoid compound extracted from a medicinal plant, Brucea javanica, for canine babesiosis. J Vet Med Sci, 71 : 33-41.
Polyzos SA,Kountouras J,Mantzoros CS .2019 .Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism, 92 : 82-97.
Powell EE,Wong VW,Rinella M .2021 .Non-alcoholic fatty liver disease. Lancet, 397 : 2212-24.
Qiu J,Chen L,Zhang L .2023 .Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy. Phytomedicine, 121 : 155111.
Ren Q,Sun Q,Fu J .2024 .Dysfunction of autophagy in high-fat dietinduced non-alcoholic fatty liver disease. Autophagy, 20 : 221-41.
Shin SY,Lee DH,Lee J .2017 .C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells. Oncotarget, 8 : 94591-605.
Sun HM,Feng QY,Qin BF .2025 .Bruceine A attenuates fibrogenesis and inflammation through NR2F2-regulated HMGB1 inflammatory signaling cascades in hepatic fibrosis. Eur J Pharmacol, 987 : 177164.
Tanaka S,Hikita H,Tatsumi T .2016 .Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice. Hepatology, 64 : 1994-2014.
Terasaki M,Ono S,Hashimoto S .2022 .Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin. J Nutr Biochem, 99 : 108871.
Tong J,Lan XT,Zhang Z .2023 .Ferroptosis inhibitor liproxstatin-1 alleviates metabolic dysfunction-associated fatty liver disease in mice: potential involvement of PANoptosis. Acta Pharmacol Sin, 44 : 1014-28.
Tufarelli V,Puvača N,Glamočić D .2024 .The Most Important Metabolic Diseases in Dairy Cattle during the Transition Period. Animals (Basel), 14 : 816.
van Attekum MHA,Terpstra S,Slinger E .2017 .Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia. Oncogene, 36 : 3651-60.
Wang S,Zhang B,Mauck J .2024 .Diacylglycerol O-acyltransferase isoforms play a role in peridroplet mitochondrial fatty acid metabolism in bovine liver. J Dairy Sci, 107 : 9897-9914.
Wu X,Poulsen KL,Sanz-Garcia C .2020 .MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcoholassociated fatty liver and steatohepatitis. J Hepatol, 73 : 616-27.
Xu H,He Y,Chen S .2025 .Blocking the CCL5/CCL7-CCR1 axis regulates macrophage polarization through NF-κB pathway to alleviate the progression of osteoarthritis. Int Immunopharmacol, 147 : 114027.
Yan J,Zuo G,Sherchan P .2020 .CCR1 Activation Promotes Neuroinflammation Through CCR1/TPR1/ERK1/2 Signaling Pathway After Intracerebral Hemorrhage in Mice. Neurotherapeutics, 17 : 1170-83.
Yan LS,Zhang SF,Luo G .2022 .Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Metabolism, 131 : 155200.
Younossi ZM .2019 .Non-alcoholic fatty liver disease-A global public health perspective. J Hepatol, 70 : 531-544.
Zhai T,Cai L,Jia X .2024 .IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFRSTAT3 pathway. Mol Metab, 89 : 102026.
Zhang C,Cao Y,Zuo Y .2023 .Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K/Akt pathway. Front Pharmacol, 14 : 1149478.
0

Citations

0

Downloads

17

Views